SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-21-013674
Filing Date
2021-04-21
Accepted
2021-04-21 16:50:17
Documents
5
Period of Report
2021-06-03

Document Format Files

Seq Description Document Type Size
1 DEF 14A nc10022459x1_def14a.htm DEF 14A 572049
2 logo_appliedtherapeutics.jpg GRAPHIC 31301
3 nc10022459x1_proxycards01.jpg GRAPHIC 499014
4 nc10022459x1_proxycards02.jpg GRAPHIC 419598
5 sig_shoshanashendelman.jpg GRAPHIC 16900
  Complete submission text file 0001140361-21-013674.txt   1903779
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38898 | Film No.: 21842237
SIC: 2834 Pharmaceutical Preparations